Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 -0.0347490347490348
Stock impact report

Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ... [Yahoo! Finance]

Clearside Biomedical, Inc. (CLSD) 
Last clearside biomedical, inc. earnings: 3/11 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.clearsidebio.com/investor-overview
Company Research Source: Yahoo! Finance
Clearside Biomedical Inc ( NASDAQ:CLSD ) reported positive results from the Odyssey phase two B clinical trial for wet AMD, demonstrating potential efficacy and safety of CLS AX. The company is the only TKI Wet AMD program with repeat dosing data, providing a competitive advantage as they advance CLS AX into phase three. Clearside's SCS microinjector has been successfully used in over 10,000 injections, showcasing its safety and reliability. The company has solidified its formulation expertise and has commercial scale microinjector manufacturing capability with ISO certification. Clearside's collaboration with Arctic Vision and Santan Pharmaceuticals highlights strategic validation of their super choroidal delivery platform. Clearside Biomedical Inc ( NASDAQ:CLSD ) has cash and cash equivalents totaling $23.6 million, which is only sufficient to fund operations into the third quarter of 2025. The company is still in the planning stages for the phase three trial of CLS AX, Show less Read more
Impact Snapshot
Event Time:
CLSD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
CLSD alerts

from News Quantified
Opt-in for
CLSD alerts

from News Quantified